疼痛灾难化与类风湿关节炎患者主观结局及炎症评估的前瞻性研究
本研究对209例已确诊的类风湿关节炎(RA)患者起始生物制剂治疗后的1、2、3、6、12个月进行随访,探索疼痛灾难化与患者报告结局(PROs)、复合评分及炎症评估的关系。疼痛灾难化与PROs及复合评分强相关,但与炎症参数(肿胀关节数、CRP、超声灰阶/能量多普勒)无关;基线高疼痛灾难化与6和12个月未达到缓解负相关。
要点
- 疼痛灾难化与PROs及复合评分强相关,与炎症参数无关。
- 高疼痛灾难化患者PROs及复合评分更高,但炎症评估无差异。
- 基线疼痛灾难化水平高负向预测6和12个月缓解。
核心结论
- 疼痛灾难化与RA患者PROs及复合评分强相关,但与炎症标志物无关。
- 高疼痛灾难化降低达到复合评分缓解的可能性,应考虑纳入达标治疗策略。
研究设计与样本
- 前瞻性纵向研究,纳入209例已确诊RA并起始生物制剂DMARDs的患者。
- 在基线及1、2、3、6、12个月进行评估,152例(72.7%)完成12个月随访。
主要发现
- 疼痛灾难化、PROs及临床和炎症评估均显著下降(P < 0.001)。
- 疼痛灾难化与PROs及复合评分强相关(P < 0.001),但与肿胀关节数、CRP水平及GS/PD超声无关。
- 高疼痛灾难化患者PROs及复合评分更高(P < 0.001),但炎症评估无差异。
- 基线疼痛灾难化与6和12个月达到缓解负相关(P < 0.05)。
关键数值与推荐
- 复合评分包括DAS28、CDAI和SDAI。
- 超声评估36个关节和4条肌腱的灰阶(GS)和能量多普勒(PD)。
临床怎么用
- 在RA达标治疗策略中应评估疼痛灾难化,因其可能影响复合评分缓解的达成。
- 高疼痛灾难化患者即使炎症控制良好,PROs和复合评分可能仍较高,需综合解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pain catastrophizing is conceptualized as a negative cognitive-affective response to anticipated or actual pain and has been associated with important pain-related outcomes. The objective of this prospective study of established rheumatoid arthritis (RA) patients was to explore how pain catastrophizing was related to patient-reported outcomes (PROs), composite scores, and assessments of inflammatory activity. METHODS: RA patients starting biologic disease-modifying antirheumatic drugs were examined at baseline and after 1, 2, 3, 6, and 12 months with PROs (joint pain/patient's global visual analog scale [VAS], modified Health Assessment Questionnaire, Rheumatoid Arthritis Impact of Disease score), clinical and laboratory assessments (tender/swollen joint count, assessor's global VAS, erythrocyte sedimentation rate/C-reactive protein [CRP] level), ultrasound (US) (gray scale [GS]/power Doppler [PD] of 36 joints and 4 tendons), and pain catastrophizing. The composite scores for Disease Activity Score in 28 joints, Clinical Disease Activity Index, and Simplified Disease Activity Index were calculated. Statistical calculations included independent samples t-test, paired samples t-test, one-way analysis of variance, Pearson's correlations, and linear and logistic regression. RESULTS: Of 209 patients included, 152 (72.7%) completed 12-month followup. Pain catastrophizing, PROs, and clinical and inflammatory assessments decreased significantly (P < 0.001). Pain catastrophizing was strongly correlated with the PROs and composite scores (P < 0.001) but not with the inflammatory parameters (swollen joint count, CRP level, and GS/PD US). Patients with higher levels of pain catastrophizing had higher PROs and composite scores during the study (P < 0.001) but not inflammatory assessments. Baseline pain catastrophizing was negatively associated with achievement of remission at 6 and 12 months (P < 0.05). CONCLUSION: Pain catastrophizing was strongly associated with PROs and composite measures, but not with markers of inflammation. High levels of pain catastrophizing reduced the likelihood of achieving composite score remission and should be a factor to consider in a treat-to-target strategy.
引用
- Hammer HB, Uhlig T, Kvien TK, et al. Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients. Arthritis Care Res (Hoboken). 2018. PMID: 28805018. doi:10.1002/acr.23339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。